Health Condition 1: A920- Chikungunya virus disease
Conditions
Interventions
Intervention1: Individualized Homoeopathic medicine: Individualized homoeopathic remedies in centesimal potencies and appropiate doses will be prescribed for oral administration based on symptom simil
Frequency: as per individualized prescription by the investigator.
Route of administration: Oral.
Duration of intervention: 1 month.
Control Intervention1: Rhustox Homoeopathic medicine: Rhustox Homoeopathic medicinewill be employed in 2nd group identified through repertorization. The trial medici
Duration of intervention: 1 month.
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients presenting with acute onset of fever more than 38.5 C and severe arthralgia/arthritis not explained by other medical conditions. 2.Patients having age between 15 to 50 years 3.Patients seropositive for IgM or IgG antibodies. 4.Patients positive for RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) during the first week of illness. 5.Patient of both sexes. 6.Patients providing Written Informed Consent.
Exclusion criteria
Exclusion criteria: 1.Patients diagnosed with Rheumatoid arthritis, osteoarthritis and gout. 2.Patients with complaint of joint pains since 1 to 4 months after H/O Chikungunya infection. 3.Patients below the age of 15 and above 50 years. 4.Immunocompromised patients. 5.Patients on DMARDs. 6.Pregnant women and lactating mother.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Changes in symptoms of chikungunya using Multi-Dimensional Health Assessment Questionnaire (MDHAQ)Timepoint: Baseline, weekly, till 4 weeks (end of treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in Visual Analogue Scale (VAS) score of pain on weekly basis till 4 weeks. (end of treatment)Timepoint: From baseline, weekly, till 4 weeks | — |
Countries
India
Contacts
Public ContactHarleen Kaur
Central Council for Research in Homoeopathy
Outcome results
None listed